Nuveen LLC Acquires New Position in MEDIFAST INC $MED

Key Points

• Nuveen LLC acquired a new stake in MEDIFAST INC, purchasing 30,185 shares worth approximately $407,000, representing about 0.27% of the company.
• Other institutional investors have significantly increased their positions in MEDIFAST, with GAMMA Investing LLC raising its stake by 3,207.2% during the first quarter.
• MEDIFAST reported a better-than-expected earnings per share of $0.04 for the previous quarter, surpassing estimates of ($0.22), with a revenue of $105.56 million.

Nuveen LLC purchased a new stake in MEDIFAST INC (NYSE:MED - Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The firm purchased 30,185 shares of the specialty retailer's stock, valued at approximately $407,000. Nuveen LLC owned about 0.27% of MEDIFAST as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Wells Fargo & Company MN lifted its holdings in shares of MEDIFAST by 23.5% during the 4th quarter. Wells Fargo & Company MN now owns 6,459 shares of the specialty retailer's stock valued at $114,000 after acquiring an additional 1,227 shares in the last quarter. Barclays PLC raised its position in MEDIFAST by 15.1% in the fourth quarter. Barclays PLC now owns 16,194 shares of the specialty retailer's stock valued at $285,000 after purchasing an additional 2,127 shares during the period. Northern Trust Corp raised its position in MEDIFAST by 0.9% in the fourth quarter. Northern Trust Corp now owns 101,775 shares of the specialty retailer's stock valued at $1,793,000 after purchasing an additional 871 shares during the period. Bridgeway Capital Management LLC acquired a new position in shares of MEDIFAST during the fourth quarter worth about $352,000. Finally, Deutsche Bank AG boosted its position in shares of MEDIFAST by 10.4% in the fourth quarter. Deutsche Bank AG now owns 29,553 shares of the specialty retailer's stock worth $521,000 after buying an additional 2,787 shares during the period. 95.51% of the stock is owned by hedge funds and other institutional investors.

MEDIFAST Stock Up 0.3%

Shares of MED traded up $0.04 during mid-day trading on Wednesday, reaching $13.84. 94,336 shares of the stock traded hands, compared to its average volume of 158,426. The stock has a fifty day simple moving average of $13.94 and a 200 day simple moving average of $13.62. MEDIFAST INC has a 12-month low of $11.57 and a 12-month high of $21.98. The firm has a market cap of $152.07 million, a price-to-earnings ratio of 43.24 and a beta of 0.82.

MEDIFAST (NYSE:MED - Get Free Report) last announced its earnings results on Monday, August 4th. The specialty retailer reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.22) by $0.26. The business had revenue of $105.56 million for the quarter, compared to analyst estimates of $96.10 million. MEDIFAST had a return on equity of 2.00% and a net margin of 0.76%. MEDIFAST has set its Q3 2025 guidance at -0.600-0.00 EPS. On average, equities research analysts expect that MEDIFAST INC will post 0.51 earnings per share for the current fiscal year.

MEDIFAST Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.